Seeing Is Believing
RPHM is currently covered by 5 analysts with an average price target of $9.55. This is a potential upside of $7.88 (471.86%) from yesterday's end of day stock price of $1.67.
Reneo Pharmaceuticals's activity chart (see below) currently has 6 price targets and 17 ratings on display. The stock rating distribution of RPHM is 60% BUY and 40% HOLD.
Analysts average stock forecasts to be materialized ratio is 5.56% with an average time for these price targets to be met of 2 days.
Highest price target for RPHM is $30, Lowest price target is $1, average price target is $9.55.
Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 15-Dec-2023. First documented stock forecast 04-May-2021.
Currently out of the existing stock ratings of RPHM, 6 are a BUY (60%), 4 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1
$-0.68 (-40.48%)
15
4 months 11 days ago
0/3 (0%)
$-0.42 (-29.58%)
Hold
1.5
$-0.18 (-10.71%)
30
4 months 11 days ago
1/3 (33.33%)
$0.08 (5.63%)
12
Hold
1.8
$0.12 (7.14%)
24
4 months 11 days ago
0/2 (0%)
$0.38 (26.76%)
Hold
4
$2.32 (138.10%)
4 months 12 days ago
0/4 (0%)
$2.66 (198.51%)
Buy
30
$28.32 (1685.71%)
30
7 months 18 days ago
0/2 (0%)
$22.89 (321.94%)
What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on RPHM (Reneo Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?